Investing Profile

Jason Rhodes

Photo of Jason Rhodes, Partner at Atlas Venture
Your Intro Paths to Jason Rhodes

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Jason Rhodes on

cb
Current Investing Position
Atlas Venture Partner
Investment Range
$500K - $5.0M
Sweet Spot
$2.0M
Investments On Record
19

Jason Rhodes is on these Sector & Stage Rankings

Jason Rhodes's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Accent Therapeutics
Series CJan 2024$75M
Series BApr 2020$63M
Series AMay 2018$40M
$180M
Co-investors: Larry Lasky (The Column Group), Naveen Krishnan (Leaps by Bayer)
K36 Therapeutics
Series BJun 2023$70M
Series ADec 2021$30M
$100M
Co-investors: Chong Xu (F-Prime Capital Partners), Melissa McCracken (Nextech Invest)
AAVantgarde Bio
Series AJun 2023$65M
$65M
Co-investors: Paola Pozzi (Soffinova Partners), Graziano Seghezzi (Soffinova Partners), Dmitrij Hristodorov (Forbion), David Steinberg (Longwood Fund)
Be Biopharma
Series BApr 2022$130M
Series AOct 2020$52M
$180M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners)
Rectify Pharmaceuticals
Series AOct 2021$100M
$100M
Co-investors: Marco Boorsma (Forbion), David Steinberg (Longwood Fund), Jodie Morrison (Atlas Venture), Rajesh Devraj (Atlas Venture)
Gemini Therapeutics
Post Ipo EquityFeb 2021$95M
Series AOct 2017$43M
SeedApr 2016$2M
$140M
Co-investors: Stephen Squinto (OrbiMed), Carl Gordon (OrbiMed), Jean George (Advanced Technology Ventures)
Generation Bio
Series CJan 2020$110M
Series AJan 2018$25M
$140M
Third Harmonic Bio
Series AJan 2019$50M
$50M
Co-investors: David Bonita (OrbiMed), Michael Gladstone (Atlas Venture)